Biotinylated Human latent GDF-8 Protein, His Tag, ultra sensitivity (primary amine labeling) (pro & latent) (MALS verified)

ユーザーレビュー
製品番号/仕様
価格
数量
GD8-H8243-25ug
$300.00
GD8-H8243-200ug
$1290.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    GDF-8, Myostatin, GDF8, MSTN, Growth, differentiation factor 8

  • Source

    Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling (GD8-H8243) is expressed from human 293 cells (HEK293). It contains AA Asn 24 - Ser 375 (Accession # O14793). It is the biotinylated form of Human latent GDF-8, His Tag (Cat. No. GD8-H5243).

    Predicted N-terminus: His

    Request for sequence
  • Molecular Characterization

    GDF-8 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus.

    The protein has a calculated MW of 42.0 kDa. The protein migrates as 38 kDa and 50-53 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a dimer.

  • Labeling

    The primary amines in the side chains of lysine residues and the N-terminus of the protein are conjugated with biotins using standard chemical labeling method. A standard biotin reagent (13.5 angstroms) is used in this product.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 0.2 M Arginine, PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    GDF-8 SDS-PAGE

    Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    GDF-8 SEC-MALS

    The purity of Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling (Cat. No. GD8-H8243) is more than 95% and the molecular weight of this protein is around 90-110 kDa verified by SEC-MALS.

    Report
  • Bioactivity-SPR

     GDF-8 SPR

    Human Follistatin Protein, His Tag, premium grade (Cat. No. FON-H52H4) immobilized on CM5 Chip can bind Biotinylated Human latent GDF-8 Protein, His Tag (Cat. No. GD8-H8243) with an affinity constant of 248 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  •  GDF-8 SPR

    Apitegromab captured on Protein A Chip can bind Biotinylated Human latent GDF-8 Protein, His Tag, primary amine labeling (Cat. No. GD8-H8243) with an affinity constant of 17.1 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Growth/differentiation factor 8

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    8 詳細

  • 最新の開発ステージ:

    NDA/BLA

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8